+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Grifols, S.A. - logo

Grifols is a leading producer of plasma-derived protein therapies for patients who have rare, genetic diseases and life-threatening infections. They are currently the largest supplier of source plasma for plasma therapy production in the world. They have built a network of 147 plasma donation centers throughout the United States and their annual plasma collection exceeds 6.5 million liters. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.

From
From
Rare Hemophilia Factors Market 2024-2028 - Product Thumbnail Image

Rare Hemophilia Factors Market 2024-2028

  • Report
  • July 2024
  • 142 Pages
  • Global
From
Hemophilia Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Hemophilia Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 143 Pages
  • Global
From
Hemostasis Products Global Market Report 2024 - Product Thumbnail Image

Hemostasis Products Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
From
Prenatal and Newborn Genetic Testing Global Market Report 2024 - Product Thumbnail Image

Prenatal and Newborn Genetic Testing Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator